Investment ThemesDetailed Quotes
Weight Loss Drugs
Watchlist
GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
- 1552.865
- -15.303-0.98%
Trading Mar 11 11:20 ET
1567.596High1543.253Low
1564.292Open1568.168Pre Close21.74MVolume--Rise38.89P/E (Static)1.97BTurnover--Flatline0.21%Turnover Ratio1.45TMarket Cap7Fall1.35TFloat Cap
Constituent Stocks: 7Top Rising: LLY-0.64%
$Viking Therapeutics (VKTX.US)$
Viking Therapeutics Locks Massive GLP-1 Supply Deal: Game-Changing Partnership Covers Both Oral and Injectable Forms
Viking's Game-Changing Manufacturing Deal Powers Billion-Dollar Obesity Drug Ambitions
If the stock can stay above 27, the uptrend is more likely to be sustainable. Go Go Go
Flight to safety to PFE once again when tech stocks sell off
$SPDR S&P 500 ETF (SPY.US)$ $Invesco QQQ Trust (QQQ.US)$
No comment yet